Status: Recruiting
Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG
The goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.
Participants needed: 11,492
Trial details
Age: 65-90Biological sex: AllType: InterventionalSponsor: National Defense Medical Center, TaiwanUpdated: Dec 12, 2025Locations: 1
Eligibility criteria
At least one 12-lead ECG within 1 year
Diagnosis of sick sinus syndrome [+4]